Health
Fortune or foresight? AstraZeneca and Oxford’s stories clash on COVID-19 vaccine – bdnews24.com
AstraZeneca and Oxford University have given conflicting accounts of how they came upon the most effective dosing pattern for their COVID-19 vaccine, a rare instance…
The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose. This diverged from the original plan of two full doses, given to the majority of participants.
The half-dose pattern was found to be 90% effective, versus the 62% success rate of the two-full-dose main study, based on interim data.
AstraZeneca’s research chief told Reuters 10 days ago, when interim trial data…
-
Noosa News23 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business21 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Business22 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General17 hours agoMigrants raise concerns over Australia’s English tests for visa applicants